BiondVax Congratulates Dirk Görlich on $1.4 million WLA

JERUSALEM, Nov. 15, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) (“BiondVax”), a biotechnology company...

Related Keywords

Germany , Jerusalem , Israel General , Israel , German , Joshua Phillipson , Matthias Dobbelstein , Amir Reichman , Max Planck Institute For Multidisciplinary Sciences , World Laureates Association , Exchange Commission On , Prize In Life Sciences Or Medicine , Biondvax Pharmaceuticals Ltd , University Medical Center , Nasdaq , Company Annual Report On Form , Corporate Communications , Prize In Life Sciences , Investorwire Biondvax Pharmaceuticals Ltd , Vax Pharmaceuticals , Max Planck Institute , Multidisciplinary Sciences , Life Sciences , Heinz Maier Leibnitz Prize , Animal Protection Research Prize , German Federal Ministry , Private Litigation Reform Act , Biondvax Pharmaceuticals , Annual Report , Exchange Commission , Nasdaq Bvxv , Biondvax , Bvxv , La Prize In Life Sciences , Biotechnology , Mmunotherapeutic Products , Healthcare , R Dirkg 246 Rlich ,